← all companiesTMO
THERMO FISHER SCIENTIFIC INC.
Manufacturing · Measuring & Controlling Devices, NEC
About
Thermo Fisher Scientific supplies laboratory instruments, reagents, diagnostics, and services for scientific research and healthcare.
Intersection with the Trump administration
In 2025 the Trump administration paused and cut National Institutes of Health research grants and reduced indirect-cost reimbursements, prompting more cautious purchasing by U.S. laboratory customers. Thermo Fisher cited these changes, with tariff exposure, in lowering the midpoint of its 2025 revenue guidance by about $500 million, and announced roughly $2 billion in U.S. manufacturing and R&D investment.
Share price · disclosed trades marked
purchase saleend-of-day close · markers placed on disclosed trade dates
Timing correlations · 12
Public statement · same day as the trade
paired with Purchase on Mar 11, 2026
“I am on my way to the Great State of Ohio, which I love and WON BIG three times, to visit Thermo Fisher, a Pharmaceutical Manufacturing Company, that is investing $2 Billion Dollars in U.S. Manufacturing, and bringing GREAT paying jobs back to Ohio from overseas. Thermo Fisher is…”
Directional consistency0.50
Disclosed trades · 6
| Date | Type | Amount range | Price at trade | Since trade |
|---|
| Mar 18, 2026 | Sale | $50,001 – $100,000 | $464.37 | +12.7% |
| Mar 17, 2026 | Sale | $1,001 – $15,000 | $464.37 | +12.7% |
| Mar 11, 2026 | Purchase | $15,001 – $50,000 | $501.97 | +4.3% |
| Mar 11, 2026 | Purchase | $15,001 – $50,000 | $501.97 | +4.3% |
|
